Large-scale testing (Phase 3)Not Yet RecruitingNCT07739888
What this trial is testing
Study to Evaluate the effIcacy and Safety of Abelacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral Anticoagulation
Who this might be right for
Atrial Fibrillation (AF)
Novartis Pharmaceuticals 2,500